F.I. Proctor Foundation, University of California San Francisco, USA.
Int Health. 2011 Jun;3(2):75-84. doi: 10.1016/j.inhe.2011.03.004.
The World Health Organization (WHO) recommends environmental improvements such as latrine construction in the integrated trachoma control strategy, SAFE. We report a cluster-randomized trial assessing the effect of intensive latrine promotion on emergence of infection with ocular Chlamydia trachomatis after mass treatment with antibiotics.Twenty-four communities in Goncha Seso Enesie woreda, Amhara Regional State, Ethiopia, were enumerated, and a random selection of 60 children aged 0- 9 years in each was monitored for clinical signs of trachoma and ocular chlamydial infection at baseline, 12 and 24 months. All community members were offered treatment with a single dose of oral azithromycin or topical tetracycline. After treatment, 12 subkebeles were randomized to receive intensive latrine promotion. Mean cluster ocular infection in the latrine and the non-latrine arms were reduced from 45.5% (95% CI 34.1-56.8%) and 43.0% (95% CI 31.1-54.8%) respectively at baseline to 14.6% (95% CI 7.4-21.8%) and 14.8% (95% CI 8.9-20.8%) respectively at 24 months (P=0.93). Clinical signs fell from 72.0% (95% CI 58.2-85.5%) and 61.3% (95% CI 44.0-78.5%) at baseline to 45.8% (36.0-55.6%) and 48.5% (34.0-62.9%) respectively at 24 months (P=0.69). At 24 months, estimated household latrine coverage and use were 80.8% and 61.7% respectively where there had been intensive latrine promotion and 30.0% and 25.0% respectively in the single treatment only arm. We were unable to detect a difference in the prevalence of ocular chlamydial infection in children due to latrine construction.
世界卫生组织(WHO)建议在沙眼综合防治策略 SAFE 中进行环境卫生改善,如修建厕所。我们报告了一项整群随机试验的结果,该试验评估了强化厕所推广对大规模使用抗生素治疗后眼部沙眼衣原体感染的影响。在埃塞俄比亚阿姆哈拉州贡恰塞索恩塞镇,对 24 个社区进行了普查,并对每个社区中随机选择的 60 名 0-9 岁儿童进行了临床沙眼和眼部衣原体感染监测,在基线、12 个月和 24 个月进行。所有社区成员均接受了单次口服阿奇霉素或局部四环素治疗。治疗后,12 个分区被随机分为强化厕所推广组。在基线时,厕所组和非厕所组的平均聚类眼部感染率分别从 45.5%(95%CI 34.1-56.8%)和 43.0%(95%CI 31.1-54.8%)降至 24 个月时的 14.6%(95%CI 7.4-21.8%)和 14.8%(95%CI 8.9-20.8%)(P=0.93)。临床体征从基线时的 72.0%(95%CI 58.2-85.5%)和 61.3%(95%CI 44.0-78.5%)降至 24 个月时的 45.8%(36.0-55.6%)和 48.5%(34.0-62.9%)(P=0.69)。在强化厕所推广的地方,24 个月时估计家庭厕所覆盖率和使用率分别为 80.8%和 61.7%,而仅接受单一治疗的地方分别为 30.0%和 25.0%。由于修建厕所,我们未能检测到儿童眼部衣原体感染率的差异。